Albemarle Corporation (ALB) Q3 Sales Rise 19% to $1.6B

What happened

Albemarle reported that Q3 2026 net sales rose 19% year over year to $1.6B, while adjusted EBITDA, a measure of operating earnings, increased $420M to $646M. The company raised its Specialties outlook and expects 2026 capital spending of $300M–$350M.

Confirmed

Global impact / market context

Higher lithium prices lifted Energy Storage sales, but that segment’s sales volume declined, so the increase did not come from selling more product. Specialties gained from both higher prices and volumes. The expected sequential Q4 decline points to possible near-term pressure on sales and profit per sale.

Analyst inference

The results combine stronger year-over-year sales and adjusted EBITDA with a weaker near-term outlook: Albemarle expects Q4 sales and adjusted EBITDA to fall from Q3 as market prices ease and it uses higher-cost spodumene inventory, a lithium-bearing raw material.

Confirmed

What to watch

1. Track whether lithium prices continue lifting Energy Storage sales, while checking whether volumes recover; the article says Q3 segment sales grew despite a volume decline. Analyst inference
2. Look for Q4 results against Albemarle’s forecast of sequentially lower sales and adjusted EBITDA, which would show how lower prices and higher-cost inventory affect earnings. Confirmed
3. Check whether the $300M–$350M 2026 capital spending plan and project-spend resequencing are maintained; the article gives no comparison with an earlier budget. Confirmed

Evidence

• Original source link unavailable